Medtronic has announced a MiniMed Insulin Pump recall for Models 630G and 670G because of a defect that could result in an incorrect insulin dosage. Filing a Medtronic MiniMed lawsuit is an option for anyone who experienced an episode of hyperglycemia or hypoglycemia while using these insulin pumps to control Type 1 diabetes.
The nationwide law firm of Bernstein Liebhard LLP has helped thousands of people injured by defective medical devices obtain the compensation they deserve. Our attorneys are currently investigating potential legal claims on behalf of Type 1 diabetics who suffered serious or life-threatening complications while using a recalled Medtronic MiniMed insulin pump, including hypoglycemia or hyperglycemia.
For a free, no-obligation case review, and to learn more about filing a Medtronic MiniMed insulin pump lawsuit, please fill out the form on this page or call our office direct at (888) 994-5118.
Type 1 diabetes – once dubbed “juvenile diabetes” because it’s generally diagnosed in childhood — occurs when the pancreas is unable to produce insulin on its own. To ensure their body has adequate insulin to effectively control blood glucose levels, Type 1 diabetics must either administer daily insulin injections or use a pump to deliver a continuous dose of insulin throughout the day.
The U.S. Food & Drug Administration (FDA) approved the Medtronic MiniMed Model 670G System in September 2016. It is currently indicated for use by Type 1 diabetics ages 7 and older. Less than a year later, the company received FDA clearance to market the MiniMed Model 630G System for use in patients 16 years of age or older.
Both Medtronic MiniMed Models consists of a continuous glucose monitor (CGM) that measures the user’s blood sugar levels for up to seven days, an insulin pump that delivers insulin, and a glucose meter used to calibrate the CGM.
In November 2019, Medtronic announced a recall of more than 322,000 MiniMed Model 670G and 630G insulin pumps because a retainer ring that locks the insulin cartridge into the pumps’ reservoir could be missing or broken. If the cartridge is not locked in place, the pump could deliver an incorrect insulin dose, resulting in hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Severe hyperglycemia can lead to loss of consciousness, seizure, and death.
The recall affected:
Months later – in February 2020 – the FDA declared the Medtronic MiniMed recall a Class 1 medical device recall , which indicates use of the insulin pumps could result in serious patient injury or death. According to the agency, Medtronic has received 26,241 complaints related to the missing or broken retainer ring. The defective MiniMed insulin pumps have also been implicated in 2,175 injuries and one patient death.
Medtronic is advising patients who use the recalled MiniMed insulin pumps to:
If you or someone you love were injured by a recalled Medtronic MiniMed Insulin Pump, filing a lawsuit may be the only way to obtain compensation for medical bills, lost wages, and other injury-related damages.
To learn if you qualify to file a claim, please contact our Medtronic MiniMed lawyers by filling out our online form or call our office today at (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.